Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-99,613
Closed -$4.58M – 814
2022
Q3
$4.58M Buy
99,613
+67,513
+210% +$3.22M 0.05% 326
2022
Q2
$1.42M Buy
+32,100
New +$1.65M 0.01% 721
2017
Q2
– Sell
-82,435
Closed -$4.83M – 454
2017
Q1
$4.83M Sell
82,435
-40,606
-33% -$2.43M 0.08% 219
2016
Q4
$7.22M Buy
123,041
+7,657
+7% +$436K 0.14% 178
2016
Q3
$6.04M Buy
+115,384
New +$5.18M 0.09% 188
2016
Q1
– Sell
-115,750
Closed -$2.66M – 516
2015
Q4
$2.95M Buy
+115,750
New +$4.23M 0.03% 285
2015
Q3
– Sell
-340,000
Closed -$18.7M – 699
2015
Q2
$18.7M Buy
+340,000
New +$21.6M 0.15% 167

Other funds holding OVV

UBS O'Connor's OVV Position: Q4 2022 in Review

UBS O'Connor sold out of Ovintiv (OVV) in Q4 2022, closing a stake of 99,613 shares — an estimated $4.58M sold.

UBS O'Connor first reported a position in OVV in Q2 2015 and held it in 7 quarters. The position peaked at $18.7M in Q2 2015. 501 funds tracked by Wall St. Rank hold OVV as of Q4 2022.

  • UBS O'Connor reported no remaining Ovintiv position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 99,613 Ovintiv shares in Q4 2022, an estimated $4.58M.
  • UBS O'Connor first reported a position in Ovintiv in Q2 2015 and held it in 7 quarters.
  • UBS O'Connor's Ovintiv position peaked at $18.7M in Q2 2015.
  • 501 funds tracked by Wall St. Rank held Ovintiv as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.